Able ANDA approvals withdrawn
Executive Summary
FDA withdraws approval of ten ANDAs held by Able effective Aug. 29. The move follows the agency's rejection of Able's proposal to return its products to market by re-validating product development data under existing ANDAs (1"The Pink Sheet" Aug. 22, 2005 In Brief)...